Stoke Therapeutics (STOK) Prepaid Assets (2018 - 2026)

Stoke Therapeutics' (STOK) quarterly Prepaid Assets came in at $6.9 million in Q1 2026, up 36.59% year-on-year from $5.0 million in Q1 2025, and down 21.25% quarter-over-quarter from $8.7 million in Q4 2025.

Stoke Therapeutics (STOK) Prepaid Assets (2018 - 2026) Analysis & Trends

Stoke Therapeutics' Prepaid Assets history runs 9 years deep, the most recent figure standing at $6.9 million for Q1 2026.

  • On a quarterly basis, Prepaid Assets rose 36.59% year-over-year to $6.9 million in Q1 2026; TTM through Mar 2026 was $6.9 million, a 36.59% increase from a year earlier, with the FY2025 full-year figure at $8.7 million, down 21.42% from the prior year.
  • Prepaid Assets slipped to $6.9 million in Q1 2026 per STOK's latest filing, from $8.7 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $13.2 million in Q2 2022 and bottomed at $3.8 million in Q3 2024.
  • The 5-year median for Prepaid Assets is $10.7 million (2024), against an average of $9.0 million.
  • Across the five-year window, Prepaid Assets slumped 65.17% in 2024 and jumped 103.39% in 2025, its largest moves.
  • Year by year, Prepaid Assets stood at $10.9 million in 2022, then climbed by 3.55% to $11.3 million in 2023, then slipped by 1.79% to $11.1 million in 2024, then fell by 21.42% to $8.7 million in 2025, then fell by 21.25% to $6.9 million in 2026.
  • Per Business Quant, the three latest STOK Prepaid Assets figures stand at $6.9 million (Q1 2026), $8.7 million (Q4 2025), and $7.7 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Stoke Therapeutics 1.87 Bn 1.53 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 6.88 Mn
Dec 31, 2025 8.74 Mn
Sep 30, 2025 7.75 Mn
Jun 30, 2025 6.87 Mn
Mar 31, 2025 5.04 Mn
Dec 31, 2024 11.12 Mn
Sep 30, 2024 3.81 Mn
Jun 30, 2024 4.29 Mn
Mar 31, 2024 10.72 Mn
Dec 31, 2023 11.32 Mn
Sep 30, 2023 10.94 Mn
Jun 30, 2023 10.95 Mn
Mar 31, 2023 5.88 Mn
Dec 31, 2022 10.93 Mn
Sep 30, 2022 12.55 Mn
Jun 30, 2022 13.18 Mn
Mar 31, 2022 12.29 Mn
Dec 31, 2021 6.94 Mn
Sep 30, 2021 8.47 Mn
Jun 30, 2021 8.61 Mn